Question 1

How does the Oncogramme® device work in selecting my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer clinical trial (NCT05299840). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of using this device compared to standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer clinical trial (NCT05299840). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my treatment plan change if I participate in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer clinical trial (NCT05299840). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer clinical trial (NCT05299840). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer clinical trial (NCT05299840). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial affect my overall treatment timeline?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Using the Oncogramme® Device to Select the First Line of Treatment for Patients With Metastatic Colorectal Cancer clinical trial (NCT05299840). Contact the study team or your healthcare provider for specific answers.

What this study is about